However, tamoxifen has been shown to have a favorable effect on the lipid profile,80, 81, 82 and in a population-based study of 17,922 patients with breast cancer, aromatase inhibitors were associated with increased risks for heart failure and cardiovascular mortality compared with the use of tamoxifen.83 Here, CYP19A1 is linked to breast carcinoma.